# Kimberly P. Cockerham, MD – FDA 483, Jun 3, 2026

Source: https://www.keypedia.com/records/483/kimberly-p-cockerham-md/5def710f-ce20-429e-ba6d-9f287740658a

> FDA 483 for Kimberly P. Cockerham, MD on June 03, 2026. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Kimberly P. Cockerham, MD
- Inspection Date: 2026-06-03
- Product Type: drugs
- Office Name: Office of Medical Device and Radiological Health Division II
- Summary: An FDA inspection of Kimberly P. Cockerham, MD in Wildwood, FL, revealed significant deviations in the conduct of a clinical investigation. The firm failed to adhere to the signed statement of investigator and investigational plan, including administering investigational product to a subject who met exclusion criteria and after unreported temperature excursions. Additionally, sponsor-provided visual acuity worksheets were not utilized for all randomized subjects.

## Related Officers

- [investigator](https://www.keypedia.com/people/emily-a-baldwin/92d70174-7029-44f4-af30-e3230d4e9507)

Company: https://www.keypedia.com/companies/kimberly-p-cockerham-md/c27b045a-d6e1-44cd-835c-1d78b6d9a8e2

Office: https://www.keypedia.com/offices/office-of-medical-device-and-radiological-health-division-ii/ae9bd439-479a-420d-9dd8-9fe1fc0863d6